CategoryMedical & Pharma
2nd International Conference on Neuropsychiatry
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2nd International Conference on Neuropsychiatry — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
2nd International Conference on Neuropsychiatry
Event Overview
The 2nd International Conference on Neuropsychiatry (ICN 2026) is a premier global gathering of researchers, clinicians, academics, and industry professionals dedicated to advancing the understanding and treatment of neuropsychiatric disorders. Scheduled from , the conference will take place at the International Conference Center in Berlin, Germany. This event bridges the gap between neuroscience and psychiatry, fostering interdisciplinary collaboration to address complex brain-behavior relationships and innovative therapeutic strategies.
Who Attends
- Researchers: Neuroscientists, psychiatrists, and biomedical scientists.
- Clinicians: Psychiatrists, neurologists, and mental health professionals.
- Academics: University professors, department heads, and medical educators.
- Industry Professionals: Pharmaceutical executives, medical device manufacturers, and biotech innovators.
- Healthcare Administrators: Hospital directors, policy-makers, and healthcare IT specialists.
Location and Geographic Origin
Venue: International Conference Center, Berlin, Germany.
Attendee Origin: Global, with a strong presence from Europe, North America, and Asia. Expected participation from over 40 countries, including leading research institutions and healthcare organizations.
Audience Reach
Type: Global, with a focus on academic and clinical communities.
This conference attracts a worldwide audience due to its interdisciplinary focus and Berlin’s status as a hub for scientific innovation. Key regions include:
- Europe (40%): Germany, UK, France, Netherlands
- North America (30%): USA, Canada
- Asia-Pacific (20%): Japan, Australia, South Korea
- Rest of the World (10%): Middle East, Africa, Latin America
Sample Buyer Institutions and Companies
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Harvard Medical School | https://www.hms.harvard.edu | Professor of Neuropsychiatry / Department Chair | Leading research institution with active neuropsychiatry programs. |
| 2 | Pfizer Inc. | https://www.pfizer.com | Director, CNS Research / Neurotherapeutics | Pharmaceutical giant investing in neurodegenerative and psychiatric drug development. |
| 3 | Mayo Clinic | https://www.mayoclinic.org | Chief of Neuropsychiatry / Clinical Director | Prominent healthcare provider integrating research and patient care in neuropsychiatry. |
| 4 | Roche Pharmaceuticals | https://www.roche.com | Head of Neuroscience Research | Industry leader in neurology and psychiatry drug discovery. |
| 5 | Stanford University School of Medicine | https://medschool.stanford.edu | Neuropsychiatry Research Fellow / Lab Director | Academic hub for cutting-edge neuropsychiatry research. |
| 6 | Medtronic Neurological Division | https://www.medtronic.com | Sales Director, Neurological Devices | Manufacturer of neurostimulation devices for psychiatric disorders. |
| 7 | Johns Hopkins University | https://www.jhu.edu | Chair, Department of Psychiatry | Renowned institution for clinical and translational neuropsychiatry research. |
| 8 | GlaxoSmithKline (GSK) | https://www.gsk.com | Senior Scientist, CNS Therapeutics | Pharmaceutical company with a focus on neurological and psychiatric therapies. |
| 9 | University of Tokyo Medical School | https://www.utokyo.ac.jp | Professor of Biological Psychiatry | Key player in Asia-Pacific neuropsychiatry research and education. |
| 10 | Abbott Diagnostics | https://www.abbott.com | Director, Neurodiagnostics | Developer of biomarker testing and diagnostic tools for neuropsychiatric conditions. |
| 11 | National Institute of Mental Health (NIMH) | https://www.nimh.nih.gov | Program Director, Translational Research | U.S. federal agency funding neuropsychiatry research initiatives. |
| 12 | University of Cambridge | https://www.cam.ac.uk | Head of Neuropsychiatry Research Group | Prominent UK institution with a strong focus on brain disorders. |
| 13 | Biogen Inc. | https://www.biogen.com | Vice President, Neurology R&D | Biotech company specializing in neurodegenerative disease therapies. |
| 14 | Karolinska Institute | https://www.ki.se | Professor of Psychiatric Genetics | Sweden’s leading medical university with expertise in neuropsychiatry. |
| 15 | Siemens Healthineers | https://www.siemens-healthineers.com | Global Lead, Neuroimaging Solutions | Medical technology company providing MRI and neuroimaging equipment. |
| 16 | University of California, San Francisco | https://www.ucsf.edu | Director, Psychiatry Research Center | Pioneer in integrating neuroscience and clinical psychiatry. |
| 17 | Eli Lilly and Company | https://www.lilly.com | Senior Medical Science Liaison, Psychiatry | Pharmaceutical leader in antidepressants and antipsychotics. |
| 18 | Max Planck Institute of Psychiatry | https://www.mpipsy.mpg.de | Research Group Leader | German research institute focused on molecular psychiatry and neurobiology. |
| 19 | Alnylam Pharmaceuticals | https://www.alnylam.com | Director, Gene Therapy Research | Biotech firm exploring genetic therapies for neurological disorders. |
| 20 | World Health Organization (WHO) | https://www.who.int | Advisor, Mental Health and Substance Use | Global health authority shaping neuropsychiatry policy and funding. |
Job Profiles, Industries, and Event Type
Target Job Profiles
- Neuropsychiatrist / Psychiatrist
- Neuroscientist / Research Scientist
- Professor / Academic Director
- Clinical Trial Manager
- Medical Director, CNS Therapeutics
- Neuroimaging Specialist
- Pharmaceutical Sales Director
- Healthcare Policy Advisor
- Biotech
Data sheet
2nd International Conference on Neuropsychiatry – Event Attendee & Buyer Profile Analysis
Event date: 06 Nov 2026 – 07 Nov 2026
Location: City Seasons Suites Dubai, Dubai, United Arab Emirates
Event status: Upcoming
Research date: 30 Jun 2026
Event Overview
| Event Name | 2nd International Conference on Neuropsychiatry |
| Event Date | 06 Nov 2026 – 07 Nov 2026 |
| Event Status | Upcoming |
| Venue | City Seasons Suites Dubai |
| City | Dubai |
| State / Region | Dubai Emirate |
| Country | United Arab Emirates |
| Organizer | Organizer not publicly confirmed in the reviewed materials. |
| Official Event Website | Official event website not publicly confirmed in the reviewed materials. |
| Event Type | International medical and scientific conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Likely international, with regional Middle East participation and broader academic/clinical outreach. |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for numerical attendance; high for event date, city, country, and venue based on provided event details. |
| Main Purpose of Event | To convene clinicians, researchers, academics, mental health specialists, and related healthcare stakeholders around neuropsychiatric disorders, brain-behavior science, treatment advances, and interdisciplinary collaboration. |
About the Event
The 2nd International Conference on Neuropsychiatry is positioned as a specialist medical and scientific meeting focused on the intersection of psychiatry, neurology, neuroscience, and behavioral health. Based on the event title and known conference format, the most likely attendee mix includes psychiatrists, neurologists, neuropsychologists, researchers, academic faculty, hospital-based clinicians, mental health practitioners, and industry organizations supporting diagnostics, therapeutics, clinical research, and medical education.
For commercial and lead-generation purposes, the event is most relevant for organizations selling clinical technologies, research solutions, pharmaceuticals, medical devices, digital mental health tools, hospital services, scientific publishing, CME/medical education offerings, and healthcare partnerships. It appears better suited for high-value expert networking, KOL outreach, clinical partnerships, and scientific business development than for mass-volume attendee list building, unless an official participant directory is released.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Hospital psychiatrists and neurologists | Public and private hospitals, neuroscience centers, specialty clinics | Clinical evaluation, treatment pathway influence, product adoption input | High relevance for diagnostics, therapeutics, decision-support tools, devices, and medical education |
| Academic researchers and principal investigators | Universities, neuroscience institutes, medical schools | Research procurement influence, collaboration partner selection, grant-linked purchasing input | Important for lab tools, data platforms, biomarkers, CROs, scientific publishing, and research software |
| Mental health service leaders | Behavioral health networks, psychiatric facilities, rehabilitation centers | Service model design, vendor review, digital care pathway decisions | Relevant for telehealth, patient monitoring, therapy support platforms, and operational services |
| Pharmaceutical and biotech medical affairs teams | Pharmaceuticals, biotech, CNS therapy developers | KOL engagement, study collaboration, therapy positioning, market education | High relevance for scientific exchange, partnerships, investigator engagement, and product awareness |
| Clinical research and trial operations professionals | CROs, hospitals, research networks, sponsor organizations | Vendor shortlisting, protocol feasibility, patient recruitment strategy | Useful for CRO services, eClinical systems, trial recruitment, and data services |
| Procurement and hospital supply teams | Hospital groups, academic medical centers, government healthcare systems | Commercial review, contract negotiation, sourcing approvals | Relevant for equipment, consumables, IT, facility services, and training contracts |
| Healthcare IT and digital health leaders | Hospitals, integrated care systems, digital health platforms | Platform selection, interoperability review, cybersecurity and analytics oversight | Relevant for EHR integration, AI decision tools, telepsychiatry, and data security services |
| Medical educators and CME program leads | Universities, associations, teaching hospitals | Educational content procurement, event partnerships, faculty coordination | Relevant for publishing, simulation, education technology, and sponsorship opportunities |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Dubai | Clinicians, hospital administrators, private healthcare operators, academic affiliates | High | Strong local base for private hospitals, specialist clinics, medical tourism, and regional conference participation |
| Dubai Emirate / UAE | UAE hospitals, regulators, universities, and healthcare investors | High | Likely attendance from Dubai, Abu Dhabi, Sharjah, and other emirates |
| GCC / Middle East | Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, and broader Gulf healthcare stakeholders | Medium to High | Dubai is a common regional event hub for healthcare and scientific meetings |
| MENA wider region | Hospitals, academic researchers, mental health professionals, distributors | Medium | Likely pull from North Africa and Levant if the organizer runs international medical conference marketing |
| International | Researchers, speakers, and industry delegates from Europe, Asia-Pacific, and North America | Medium | The term “International Conference” suggests broader recruitment, but current-year country mix is not publicly confirmed |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The event branding is international, and Dubai is a common global conference destination. However, participant-country distribution is not publicly confirmed. |
| Regional | Secondary practical reach | Commercially, the strongest likely buyer concentration is in the UAE and broader Gulf/MENA healthcare ecosystem. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Dubai Health | Government healthcare system / hospital operator | Major healthcare authority and provider ecosystem in the host city; relevant for psychiatry, neurology, research, procurement, and digital health engagement | dubaihealth.ae | Director of Psychiatry, Neurology Department Head, Procurement Manager, Clinical Research Director | Confirmed Government / Procurement Organization |
| Dubai Health Authority | Government regulator / healthcare buyer | Relevant for public health policy, mental health regulation, hospital networks, and strategic healthcare programs in Dubai | dha.gov.ae | Mental Health Program Lead, Procurement Specialist, Health Strategy Director | Confirmed Government / Procurement Organization |
| Ministry of Health and Prevention UAE | Federal government healthcare body | Relevant for national health initiatives, care standards, public healthcare buying, and policy influence | mohap.gov.ae | Department Director, Clinical Programs Manager, Government Procurement Officer | Confirmed Government / Procurement Organization |
| SEHA | Public healthcare provider network | Large UAE healthcare system with relevance for mental health, neurology, and hospital procurement pathways | seha.ae | Medical Director, Procurement Manager, Director of Neurosciences, Clinical Operations Director | Confirmed Government / Procurement Organization |
| Cleveland Clinic Abu Dhabi | Tertiary care hospital | High-value target for neuroscience, psychiatry, research collaboration, specialty care technology, and clinician education | clevelandclinicabudhabi.ae | Chair of Neurology, Psychiatry Lead, Research Director, Supply Chain Director | Strong Market Fit, Attendance Not Confirmed |
| Mediclinic Middle East | Private hospital group | Operates hospitals and clinics in the UAE; relevant for specialty care procurement, digital health, and physician engagement | mediclinic.ae | Head of Mental Health, Procurement Director, Hospital CEO, Medical Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| American Hospital Dubai | Private hospital | Important local buyer-side target for specialty clinical services, diagnostics, and healthcare technology | ahdubai.com | Neurology Service Lead, Psychiatry Lead, Director of Procurement, CIO | Strong Market Fit, Attendance Not Confirmed |
| Al Jalila Children’s Specialty Hospital | Specialty hospital | Relevant for pediatric neurodevelopmental and neuropsychiatric care pathways, research, and medical education | aljalilahospital.ae | Pediatric Neurology Lead, Clinical Services Director, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Mohammed Bin Rashid University of Medicine and Health Sciences | Academic medical institution | Relevant for faculty participation, clinical research, training, and educational partnerships | mbru.ac.ae | Dean, Department Chair, Research Director, Grants Manager | Strong Market Fit, Attendance Not Confirmed |
| United Arab Emirates University College of Medicine and Health Sciences | Medical school / research institution | Relevant for neuroscience research, academic attendance, and collaboration opportunities | uaeu.ac.ae | Professor of Psychiatry, Research Chair, Laboratory Director, Procurement Officer | Strong Market Fit, Attendance Not Confirmed |
Current-year buyer-side participant list was not publicly available in the reviewed materials. The table above combines confirmed healthcare/government buyer organizations relevant to the host market and strong prospecting targets for outreach around the event. These are not confirmed current-year attendees unless explicitly stated.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Psychiatry | Clinical Services | Director | High influence over treatment pathways, clinical pilots, and physician adoption |
| 2 | Head of Neurology / Neurosciences | Clinical Services | Director / VP | Key decision-maker for neurological and neuropsychiatric tools, programs, and partnerships |
| 3 | Clinical Research Director | Research | Director | Relevant for trials, collaboration agreements, data platforms, and investigator networks |
| 4 | Procurement Manager | Procurement / Supply Chain | Manager | Important for vendor onboarding, commercial review, and contract workflow |
| 5 | Chief Medical Officer | Executive Leadership | C-Level | Executive sponsor for strategic clinical investments and partnerships |
| 6 | Medical Affairs Director | Medical Affairs | Director | Critical in pharma/biotech partnership, KOL, and scientific communications engagement |
| 7 | Professor / Department Chair of Psychiatry | Academia | Director / Executive | High-value academic influencer for research programs and institutional partnerships |
| 8 | CIO / Health IT Director | Information Technology | Director / VP / C-Level | Relevant for digital therapeutics, analytics, EHR integration, AI, and secure clinical platforms |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core attendee base for psychiatry, neurology, and clinical operations | Hospital buyers, clinicians, administrators, specialty centers |
| 2 | Medical Devices | Relevant for neurodiagnostics, monitoring, imaging-adjacent tools, and treatment devices | Clinical equipment and neurotechnology selling |
| 3 | Pharmaceuticals | CNS therapies and neuropsychiatric treatment innovation are directly aligned | Medical affairs, therapeutic partnerships, investigator relations |
| 4 | Biotechnology | Relevant for biomarkers, translational medicine, genomics, and CNS pipeline innovation | R&D collaboration and scientific partnerships |
| 5 | Research | Academic and translational research institutions are likely core participants | Research collaboration, software, lab services, publications |
| 6 | Higher Education | Medical schools and academic departments likely send speakers and faculty | Academic engagement and educational partnerships |
| 7 | Government Administration | Public health systems and regulators are relevant in UAE and regional care ecosystems | Public health policy, procurement, hospital oversight |
| 8 | Information Technology & Services | Digital mental health, analytics, interoperability, and AI are strong adjacent solutions | Health IT, telepsychiatry, analytics, secure platforms |
| 9 | Computer Software | Clinical software and digital therapeutics can be relevant buyer-side solutions | Clinical workflow, research systems, patient engagement |
| 10 | Health, Wellness & Fitness | Relevant for mental wellness tools and supportive care models | Behavioral health programs and wellness-adjacent offerings |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No verified organizer attendance data available in the reviewed materials | Do not use for list-size assumptions without official confirmation |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No official exhibitor prospectus or exhibitor list reviewed | Conference may be sponsor-led rather than exhibition-heavy |
| Buyer count | Not publicly confirmed | Unconfirmed | No attendee segmentation breakdown available | Likely strong clinician/researcher mix rather than pure procurement audience |
| Speaker count | Not publicly confirmed | Unconfirmed | No verified agenda or speaker directory reviewed | Speaker organizations would be useful for KOL targeting once published |
| Sponsor count | Not publicly confirmed | Unconfirmed | No verified sponsor listing reviewed | Sponsor list would improve buyer-side and competitor intelligence |
| Historical attendance | Historical attendance not publicly confirmed in the reviewed materials | Historical / prior-year evidence unavailable | No prior-year official statistics reviewed | A prior-year brochure would materially improve forecast quality |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Neuropsychiatric treatment innovation | Better treatment outcomes and evidence-based care tools | Clinical demos, scientific exchange, pilot studies | Pharmaceuticals, medical devices, diagnostic tools |
| Clinical research | Study support, data capture, trial collaboration, biomarker validation | Investigator meetings, partnership outreach, protocol feasibility discussions | CRO services, data platforms, analytics, recruitment solutions |
| Mental health services | Operational efficiency, patient access, continuity of care | Service redesign discussions and provider network partnerships | Telehealth, patient monitoring, workflow systems |
| Digital transformation | Interoperable systems, patient data access, secure collaboration | IT leadership meetings and pilot program discussions | Health IT, AI software, cloud-enabled clinical platforms |
| Medical education and CME | Faculty content, accredited learning, professional development | Education partnerships, sponsored sessions, publication support | Publishing, learning systems, simulation, training content |
| Hospital procurement | Validated solutions with clinical and commercial justification | Shortlist creation, vendor meetings, procurement follow-up | Devices, services, software, consumables, consulting |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong relevance for clinical, research, healthcare IT, and therapy-related suppliers |
| Decision-maker availability | Medium to High | Likely presence of clinical leaders, department heads, and academic influencers; pure procurement concentration may be lower than at a buying expo |
| Data collection potential | Medium | Good if speaker, sponsor, and attendee directories become available; currently limited by lack of public lists |
| Apollo targeting potential | High | Clear institutional targeting exists across hospitals, universities, pharma, biotech, and public health bodies |
| Geographic targeting potential | High | Dubai, UAE, and GCC provide a practical regional account list for outreach before and after the event |
| Best outreach approach | High-touch ABM | Best results likely from KOL-led messaging, clinical-value positioning, research collaboration, and targeted executive outreach |
| Overall lead quality | High | High-value niche audience with good fit for specialized healthcare and research offerings |
| Best use case | Relationship-based pipeline building | Best for strategic outreach, hospital partnerships, clinical pilots, and academic alliances rather than bulk list monetization |
| Limitations / risks | Medium | Public attendee transparency is currently limited; confirmed current-year participant data should be monitored closely |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Government Administration; Information Technology & Services; Computer Software | Build a buyer universe aligned to neuropsychiatry and adjacent healthcare ecosystems |
| Departments | Medical; Clinical; Research; Procurement; Supply Chain; Information Technology; Operations; Executive; Business Development | Target both clinical influencers and commercial approvers |
| Seniority | C-Level; VP; Director; Head; Manager; Partner; Professor | Reach decision-makers and high-authority influencers |
| Job titles | Director of Psychiatry; Head of Neurology; Chief Medical Officer; Medical Director; Clinical Research Director; Procurement Manager; Supply Chain Director; CIO; Health IT Director; Professor of Psychiatry; Department Chair; Medical Affairs Director | Improve role-based relevance for outreach sequences |
| Geography | United Arab Emirates; Dubai; Abu Dhabi; Sharjah; Saudi Arabia; Qatar; Kuwait; Bahrain; Oman; broader MENA as secondary | Align to likely regional attendee and buyer concentration |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Capture hospitals, university systems, public entities, and enterprise healthcare organizations |
| Keywords | psychiatry, neurology, neuroscience, neuropsychiatry, behavioral health, mental health, clinical research, digital health, medical education, CNS | Narrow accounts and contacts to event-relevant specialties |
| Technologies, if relevant | EHR, telehealth, clinical analytics, AI healthcare, patient engagement platforms | Useful for digital solution providers seeking high-fit accounts |
| Revenue range, if relevant | Mid-market to enterprise; public health systems and major hospital groups | Focus on organizations with budget capacity and implementation scale |
| Company type | Hospitals; Academic medical centers; Government health bodies; Pharma; Biotech; Research institutes; Private healthcare groups | Concentrates outreach on realistic event-relevant buyer organizations |
Suggested Apollo Search Logic: ("psychiatry" OR "neuropsychiatry" OR "neurology" OR "neuroscience" OR "behavioral health" OR "mental health") AND ("director" OR "head" OR "chief" OR "professor" OR "medical affairs" OR "procurement") within UAE and GCC healthcare, research, pharma, and academic accounts. Build separate lists for clinical influencers, procurement approvers, and research collaboration targets.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Provided event details | Event title, venue, city, country, and event dates used for this report | High for provided details; external organizer verification still recommended |
| City Seasons Hotels | Venue / hospitality website | Venue group reference for City Seasons Suites Dubai | Medium |
| Visit Dubai | Destination / government-backed tourism source | Dubai as host city and conference destination context | Medium |
| Ministry of Health and Prevention UAE | Government source | Federal healthcare ecosystem relevance and buyer-side target validation | High |
| Dubai Health Authority | Government source | Dubai healthcare oversight relevance and buyer-side target validation | High |
| Dubai Health | Public healthcare system source | Host-city healthcare buyer ecosystem relevance | High |
Verification note: current-year organizer, official website, attendee list, sponsor list, exhibitor list, agenda, and attendance figures were not publicly confirmed in the reviewed materials. This event appears suitable for targeted B2B account-based outreach and expert-network prospecting, but only moderately suitable for current-year attendee list building until official participant data is published.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2nd International Conference on Neuropsychiatry — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds